Posts

ELCC 2023 | Expert Interview: The Role of Radiotherapy in the Treatment of Stage III Thymoma

ELCC 2023 | Chairman's Remarks: Dr. Reck Takes Stock of Important Oral Presentations at ELCC

ELCC 2023 | Researcher Interview: P. Garrido Lopez Interprets Latest Data from CHRYSALIS

ELCC 2023 | International Scholar Dr. Girard Deciphers Key Research Advances at ELCC

AACR 2023 | AEGEAN Trial: New Data on Neoadjuvant Chemotherapy/Immunotherapy + Adjuvant Immunotherapy Released

SGBCC International Dialogue | Wang Jia & Professor William Gradishar: Controversies in Surgical Treatment for Stage IV Breast Cancer Patients at Initial Diagnosis

Advancements in Breast-Conserving Treatment: Insights from Monica Morrow

WCLC 2023 | Dr. Harpole: Surgical outcomes from AEGEAN trial and subgroup analyses of patients who were EGFR-mutant

WCLC 2023 | Dr. Drilon: Advances in MET Target therapy released in 2023 WCLC

WCLC 2023 | Acceptance Speech by 2023 Distinguished Service Award Winner Dr. Ramalingam

WCLC 2023 |Dr. Reguart reviews three important small cell lung cancer immunotherapy studies

WCLC 2023 | Talking with the co-chairs Dr. Hegi-Johnson about the theme and important issues

WCLC 2023 |Dr. Gainor reviews IMpower151: Is the high percentage of patients with EGFR mutations, the reason for the research’s failure ?